BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18398016)

  • 1. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.
    Martins P; Schmitt F; Almeida H; Frazão JM
    Nephrol Dial Transplant; 2008 Sep; 23(9):2889-94. PubMed ID: 18398016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesions.
    Lazaris AC; Tseleni-Balafouta S; Papathomas T; Brousalis T; Thomopoulou G; Agrogiannis G; Patsouris ES
    Eur J Endocrinol; 2006 Jun; 154(6):827-33. PubMed ID: 16728542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
    Garcia de la Torre N; Buley I; Wass JA; Jackson DG; Turner HE
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2890-6. PubMed ID: 15181073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy.
    Vulpio C; Bossola M; Di Stasio E; Tazza L; Silvestri P; Fadda G
    Eur J Endocrinol; 2013 Jun; 168(6):811-9. PubMed ID: 23520248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
    Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
    Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
    Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
    Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
    J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S; Zhang W; Mao J; Wang M; Ni L; Zhang M; Zhang Q; Chen J
    J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound patterns of parathyroid glands in chronic hemodialysis patients with secondary hyperparathyroidism.
    Vulpio C; Bossola M; De Gaetano A; Maresca G; Di Stasio E; Spada PL; Romitelli F; Luciani G; Castagneto M
    Am J Nephrol; 2008; 28(4):589-97. PubMed ID: 18277066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
    Chen XJ; Chen X; Wu WJ; Zhou Q; Gong XH; Shi BM
    J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
    Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging.
    Sukan A; Reyhan M; Aydin M; Yapar AF; Sert Y; Canpolat T; Aktas A
    Ann Nucl Med; 2008 Feb; 22(2):123-31. PubMed ID: 18311537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.
    Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG
    Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evocalcet prevents ectopic calcification and parathyroid hyperplasia in rats with secondary hyperparathyroidism.
    Sakai M; Tokunaga S; Kawai M; Murai M; Kobayashi M; Kitayama T; Saeki S; Kawata T
    PLoS One; 2020; 15(4):e0232428. PubMed ID: 32343734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
    Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
    Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
    Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
    Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.